OLD Category: Oncology

Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci

• Roberto D et al.,

Defining fallopian tube‐derived miRNA cancer signatures

• Dejene SB et al.,

Panoptic View of Prognostic Models for Personalized Breast Cancer Management

• Saini G et al.,

Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes

• McQuerry JA et al.,

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

• Zhang F et al.,

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

• Jacquelot N et al.,

Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma

• kodama T et al.,

YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma

• Tu B et al.,

MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages

• Khalife J et al.,

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

• Yang Y et al.,

Extracellular vesicles in urologic malignancies—Implementations for future cancer care

• Wu Z et al.,

Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience

• Tsang DS et al.,